Preparation of novel azabicyclic arnines and α7 nicotinic acetylcholine receptor activity of derived aryl amides

被引:6
|
作者
Walker, Daniel P. [1 ]
Acker, Brad A. [1 ]
Jacobsen, E. Jon [1 ]
Wishka, Donn G. [1 ]
机构
[1] Pfizer Inc, Pfizer Global Res & Dev, Chesterfield, MO 63017 USA
关键词
D O I
10.1002/jhet.5570450131
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Three new azabicyclic amines, namely exo-3-amino-1-azabicyclo[3.2.1]octane, 3-amino-1-azabicyclo[3.2.2]nonane and exo-6-amino-8-azabicyclo[3.2.1]octane, have been designed and prepared as isosteres of 3-aminoquinuclidine. Aryl amides derived from each series were prepared and tested in an alpha 7 nicotinic acetylcholine receptor assay as part of a drug discovery program to treat the cognitive deficits in schizophrenia. All new amides showed significant alpha 7 nAChR activity and one series displayed potent alpha 7 activity equal to the quinuclidine series.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 50 条
  • [41] Antishock effect of anisodamine involves a novel pathway for activating α7 nicotinic acetylcholine receptor
    Liu, Chong
    Shen, Fu-Ming
    Le, Ying-Ying
    Kong, Yan
    Liu, Xia
    Cai, Guo-Jun
    Chen, Alex F.
    Su, Ding-Feng
    CRITICAL CARE MEDICINE, 2009, 37 (02) : 634 - 641
  • [42] A Novel Peptide Driving Neurodegeneration Appears Exclusively Linked to the α7 Nicotinic Acetylcholine Receptor
    Ranglani, Sanskar
    Hasan, Sibah
    Komorowska, Joanna
    Medina, Nathalia Mayag
    Mahfooz, Kashif
    Ashton, Anna
    Garcia-Rates, Sara
    Greenfield, Susan
    MOLECULAR NEUROBIOLOGY, 2024, 61 (10) : 8206 - 8218
  • [43] HUMAN ALPHA-7 NICOTINIC ACETYLCHOLINE-RECEPTOR RESPONSES TO NOVEL LIGANDS
    BRIGGS, CA
    MCKENNA, DG
    PIATTONIKAPLAN, M
    NEUROPHARMACOLOGY, 1995, 34 (06) : 583 - 590
  • [44] Discovery, synthesis, and structure activity of a highly selective α7 nicotinic acetylcholine receptor antagonist
    Whiteaker, Paul
    Christensen, Sean
    Yoshikami, Doju
    Dowell, Cheryl
    Watkins, Maren
    Gulyas, Jozsef
    Rivier, Jean
    Olivera, Baldomero M.
    McIntosh, J. Michael
    BIOCHEMISTRY, 2007, 46 (22) : 6628 - 6638
  • [45] SAR of α7 nicotinic receptor agonists derived from tilorone: Exploration of a novel nicotinic pharmacophore
    Schrimpf, Michael R.
    Sippy, Kevin B.
    Briggs, Clark A.
    Anderson, David J.
    Li, Tao
    Ji, Jianguo
    Frost, Jennifer M.
    Surowy, Carol S.
    Bunnelle, William H.
    Gopalakrishnan, Murali
    Meyer, Michael D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (04) : 1633 - 1638
  • [46] Characterization of a novel nicotinic acetylcholine receptor α7 (α7 nAChR) positive modulator in recombinant and native systems
    Hirakawa, Ryoko
    Maag, Hans
    Misner, Dinah
    Milla, Marcos
    Button, Donald
    Sahdeo, Sunil
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : SMA35 - SMA35
  • [47] Fluorescent Agonists of the 7 Nicotinic Acetylcholine Receptor Derived from 3-Amino-Quinuclidine
    Burgi, Justus J.
    Bertrand, Sonia
    Marger, Fabrice
    Bertrand, Daniel
    Reymond, Jean-Louis
    HELVETICA CHIMICA ACTA, 2016, 99 (10) : 790 - 804
  • [48] Structural determinates for apolipoprotein E-derived peptide interaction with the α7 nicotinic acetylcholine receptor
    Gay, Elaine A.
    Bienstock, Rachelle J.
    Lamb, Patricia W.
    Yakel, Jerrel L.
    MOLECULAR PHARMACOLOGY, 2007, 72 (04) : 838 - 849
  • [49] Nicotinic Modulation of Innate Immune Pathways Via α7 Nicotinic Acetylcholine Receptor
    Cui, Wen-Yan
    Li, Ming D.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2010, 5 (04) : 479 - 488
  • [50] Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor
    Lee, J
    Davis, CB
    Rivero, RA
    Reitz, AB
    Shank, RP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (10) : 1063 - 1066